Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer
Sponsor: Dartmouth-Hitchcock Medical Center
A observational or N/A phase clinical study on Non-Small Cell Lung Cancer, this trial is completed. The trial is conducted by Dartmouth-Hitchcock Medical Center and has accumulated 12 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Feb 2023 — Sep 2023 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Mar 2021 — Feb 2023 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Sep 2018 — Apr 2019 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status · Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dartmouth-Hitchcock Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .